GGrantIndex
Sort

11,323 grants matching glioblastoma

Epigenetic Mechanisms of Oncohistone Detoxification

$56,694
Katharine Diehl · Princeton University · F32 · FY2017 · CA

Exploring the regulation and function of gap junction-mediated signaling in glioblastoma multiforme

$56,694
Bethany Schaffer · Weill Medical Coll Of Cornell Univ · F32 · FY2017 · CA

Complement activation promotes CD133+ glioma cell proliferation

$56,619
Michael C Oh · University Of California, San Francisco · F32 · FY2011 · NS

PROGRAM LEADERS--CANCER BIOLOGY

$56,566
Larry Donehower · Baylor College Of Medicine · P30 · FY2013 · CA

Role of integrin in postnatal &pathologic angiogenesis

$56,536
Sloan-Kettering Institute For Cancer Res · F32 · FY2004 · CA

Cancer Molecular Imaging

$56,472
Anna M Wu · University Of California Los Angeles · P30 · FY2010 · CA

Project 05: Translational Therapeutics (TT)

$56,328
David P Carbone · Ohio State University · P30 · FY2022 · CA

Loss of oncogene insulation drives IDH1 mutant glioma

$56,118
William Alexander Flavahan · Massachusetts General Hospital · F32 · FY2016 · CA

Regulation of glioma stem cell malignancy by neural activity in the tumor niche

$56,118
Julia Pollak · Seattle Children'S Hospital · F32 · FY2016 · CA

Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma

$56,103
Constantinos George Hadjipanayis · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

Non-canonical signal pathway for Crk in breast cancer

$55,994
Raymond B Birge · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2013 · CA

Phase I Study of Dendritic Cell Immunotherapy

$55,968
University Of California Los Angeles · R21 · FY2002 · CA

Administrative Supplement: Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer

$55,777
Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2018 · CA

Dual LSD1 and HDAC Inhibition for Cancer Therapy

$55,670
Melissa Marie Singh · University Of Tx Md Anderson Can Ctr · F32 · FY2012 · CA

Functional proteoform analysis of the glioma oncogene idh1

$55,433
Kenneth David Clevenger · Northwestern University · F32 · FY2016 · GM

Brain Cancer Program - 09

$55,386
Stuart A Grossman · Johns Hopkins University · P30 · FY2021 · CA

Brain Cancer Program - 09

$55,386
Stuart A Grossman · Johns Hopkins University · P30 · FY2019 · CA

Brain Cancer Program - 09

$55,386
Stuart A Grossman · Johns Hopkins University · P30 · FY2020 · CA

Brain Cancer Program - 09

$55,372
Stuart A Grossman · Johns Hopkins University · P30 · FY2018 · CA

Brain Cancer Program - 09

$55,301
Stuart A Grossman · Johns Hopkins University · P30 · FY2017 · CA

NABTT-New Approaches to Brain Tumor Therapy (CNSC)

$55,269
Massachusetts General Hospital · U01 · FY2004 · CA

Cancer as a Complex Adaptive System

$55,215
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA

Role of Ascl1 in glioma

$55,094
Tou Yia Vue · Ut Southwestern Medical Center · F32 · FY2014 · CA

IN VIVO PHARMACOTYPING OF COMBINATION THERAPY IN PRIMARY BRAIN TUMORS

$55,000
Christian Knoopke · Lodestone Biomedical, Llc · N43 · FY2021 · CA

Development of GB13 for the Treatment of Pediatric Diffuse Intrinsic Pontine Glioma

$55,000
Randy Schrecengost · Targepeutics, Inc. · R43 · FY2023 · CA